n2 based on PK metric with higher CV [Two-Stage / GS Designs]

posted by Elena777 – Belarus, 2019-09-16 21:48 (2122 d 12:38 ago) – Posting: # 20601
Views: 13,832

Dear Helmut,

Still need some clarifications on the question from Astea:

❝ a) first step - estimated power is less than target (80%) for Cmax and more than target for AUC, besides 90%CI for AUC is OK.


To be in compliance with method C of Potvin, we re-calculate CI for Cmax with α=0,0294. Let`s assume that BE criterion for Cmax is met after this step. Should we also re-calculate CI for AUC with α=0,0294? Otherwise, finally we will have the following in a CSR: BE criterion was met for AUC using α=0,05 (90%CI) and BE criterion was met for Cmax using α=0,0294 (94,12% CI). Does it look OK?

Complete thread:

UA Flag
Activity
 Admin contact
23,428 posts in 4,929 threads, 1,693 registered users;
60 visitors (0 registered, 60 guests [including 29 identified bots]).
Forum time: 10:26 CEST (Europe/Vienna)

If I’d observed all the rules,
I’d never have got anywhere.    Marilyn Monroe

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5